GLABF (Gemina Laboratories) Interest Coverage: 0 (At Loss) (As of Oct. 2025)


What is Gemina Laboratories Interest Coverage?

Gemina Laboratories GLABF -27.59% Interest Coverage is 0 (At Loss) as of Oct. 2025. The stock has 2 warning signs investors should review.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Gemina Laboratories's Operating Income for the three months ended in Oct. 2025 was $-0.24 Mil. Gemina Laboratories's Interest Expense for the three months ended in Oct. 2025 was $0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Gemina Laboratories's Interest Coverage or its related term are showing as below:


GLABF's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.07
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gemina Laboratories  (OTCPK:GLABF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Gemina Laboratories Interest Coverage Related Terms

Gemina Laboratories Interest Coverage Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Gemina Laboratories Interest Coverage Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Interest Coverage
N/A 0.00 N/A 0.00 0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GLABF vs VRTX, REGN, ALNY: Interest Coverage Comparison

For the Biotechnology subindustry, Gemina Laboratories's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Interest Coverage falls into.


Gemina Laboratories Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gemina Laboratories's Interest Coverage for the fiscal year that ended in Jan. 2025 is calculated as

Here, for the fiscal year that ended in Jan. 2025, Gemina Laboratories's Interest Expense was $-0.11 Mil. Its Operating Income was $-2.72 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.12 Mil.

Gemina Laboratories did not have earnings to cover the interest expense.

Gemina Laboratories's Interest Coverage for the quarter that ended in Oct. 2025 is calculated as

Here, for the three months ended in Oct. 2025, Gemina Laboratories's Interest Expense was $0.00 Mil. Its Operating Income was $-0.24 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Gemina Laboratories (GLABF) has a Interest Coverage of 0 (At Loss) as of Oct. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Interest Coverage too high?
Gemina Laboratories' current Interest Coverage is 0 (At Loss).
How does Gemina Laboratories' Interest Coverage compare to VRTX and REGN?
Gemina Laboratories' Interest Coverage of 0 (At Loss) can be compared against companies in the Biotechnology industry. The industry median Interest Coverage is 106.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Gemina Laboratories and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gemina Laboratories's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Interest Coverage is 0 (At Loss) as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.